The medical landscape of South Texas is undergoing a profound transformation as specialized clinicians at Methodist Healthcare pioneer the transition of chimeric antigen receptor T-cell therapy from a niche oncological intervention to a versatile therapeutic platform for complex diseases.
The persistent gap between the rapid generation of computational molecular designs and the slow physical validation of those molecules has become the primary bottleneck in contemporary therapeutic development. While artificial intelligence has succeeded in expanding the horizon of potential drug
The frontier of synthetic biology has moved beyond the mere editing of existing organisms toward the radical construction of entirely new life forms from inanimate chemical components. For decades, the primary strategy involved stripping genetic material from bacteria until only the essentials
The daily reality for millions of individuals living with Type 1 diabetes has long been defined by a relentless cycle of glucose monitoring and insulin administration that leaves little room for error or spontaneity. For decades, the medical community sought a definitive solution that could restore
The traditional boundaries between biological systems and mechanical engineering have blurred as researchers move beyond the static limitations of rational design to embrace the chaotic yet efficient power of natural selection. For decades, the ambition of protein engineering was restricted by the
The global manufacturing landscape is currently undergoing a radical transformation as industries seek to replace traditional petroleum-dependent processes with sustainable, bio-based alternatives that utilize engineered microorganisms. This paradigm shift, often referred to as biomanufacturing,